MEDICLUS Co., Ltd. is a research and development–driven dental materials company whose name combines “Medical” and “Cluster,” reflecting its vision to shape the future of Korean dental technology.

Founded in 2011 as a women-led enterprise, MEDICLUS develops differentiated dental materials based on proprietary technologies and advanced material innovation. With a strong foundation in R&D and specialized expertise, the company contributes to the advancement of the global dental industry. Through continuous research and technological innovation, MEDICLUS has secured a wide range of core technologies.

The company independently develops and manufactures over 45 products, including light-cured restorative materials, temporary restorative materials, and endodontic materials. With a strict quality management system certified by ISO 13485 and KGMP, MEDICLUS exports its products to more than 90 countries worldwide. Its major products have obtained international regulatory approvals such as FDA, CE, China NMPA (CFDA), Japan MHLW, and Russia GOST-R, demonstrating globally recognized quality and safety.

In particular, MEDICLUS is committed to a clinician-centered product development philosophy, continuously validating usability and reliability in real clinical environments. As a result, the company has earned high recognition from dental professionals both domestically and internationally.

Furthermore, through sustained investment in research and development, MEDICLUS has established advanced facilities and a strong R&D infrastructure, striving to deliver innovative dental solutions that differentiate its products in the global market.

Moving forward, MEDICLUS will remain committed to its founding principles as a responsible company, leading the global dental materials industry through continuous innovation and quality enhancement.